Company / Free Cash Flow per Share
ResMed Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$11.31
FY2025
5-year range
$1.49 / $11.31
FY2021-FY2025
Trend
+27.8%
vs FY2024
Sector context
#18 of 142
Health Care
What the data says
ResMed's free cash flow per share of $11.31 is higher than 87% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has increased for 3 consecutive years, from $1.49 in FY2022 to $11.31 in FY2025.
Based on SEC 10-K filings.
11.31 in FY2025 with a 5-year CAGR of +18.1%. Top quartile in the Health Care sector.
Improved from $3.92 to $11.31 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +96.8%
- 5-Year CAGR
- +18.1%
- 10-Year CAGR
- -
Sector benchmark
+119.0% above sector average
Key checks
Key Insights
- ResMed's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 27.8% year-over-year.
- Ranks #18 out of 142 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.31 | +27.8% |
| FY2024 | $8.85 | +125.9% |
| FY2023 | $3.92 | +163.8% |
| FY2022 | $1.49 | -66.1% |
| FY2021 | $4.38 | -11.1% |
| FY2020 | $4.92 | +79.9% |
| FY2019 | $2.74 | -12.1% |
| FY2018 | $3.11 | +24.4% |
| FY2017 | $2.50 | -28.2% |
| FY2016 | $3.48 | +52.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026